Gaucher disease is a lysosomal storage disease of glycolipids, with accumulation of glucosylceramide (glucocerebroside). The disease can be divided into different clinical phenotypes based on clinical findings.
Major Types:
(1) Type 1 - nonneuronopathic
(2) Type 2 - acute neuronopathic with severe neurologic involvement
(3) Type 3 - subacute neuronopathic
Subtypes of Type 3:
(1) Type 3a - progressive neurologic disease with myoclonus and dementia
(2) Type 3b - visceral and skeletal disease with horizontal supranuclear gaze palsy
(3) Type 3c - corneal opacities, cardiac valve calcifications, horizontal supranuclear gaze palsy
Factor |
Type 1 |
Type 2 |
Type 3a |
Type 3b |
Type 3c |
ethnic group |
Ashkenazi Jew |
none |
northern Swedish |
none |
none |
onset |
variable |
infancy |
childhood |
childhood |
childhood |
hepato-spleno-megaly |
mild to severe |
mild |
severe |
severe |
mild |
bone disease |
mild to severe |
none |
moderate |
severe |
mild |
neurologic disease |
none |
severe |
moderate |
none to mild |
none |
survival if untreated |
child to old age |
infancy to toddler |
early to mid adult |
early to mid adult |
early to mid adult |
after Table 146-1, page 3637.
Specialty: Genetics
ICD-10: ,